1.
|
Phase: Phase III Type: Treatment Status: Completed Age: no age specified Sponsor: NCI, Other Protocol IDs: DM95-231, P30CA016672, MDA-DM-95231, NCI-G96-1044, CDR0000065105, NCT00002855
|
|
2.
|
Phase: Phase III Type: Treatment Status: Closed Age: postpubertal Sponsor: Protocol IDs: EORTC-40861
|
|
3.
|
Phase: Phase III Type: Treatment Status: Completed Age: 40 to 85 Sponsor: Protocol IDs: FCCC-86814, NCI-V87-0282
|
|
4.
|
Phase: Phase III Type: Treatment Status: Closed Age: Under 80 Sponsor: Other Protocol IDs: CDR0000270970, FRE-FNCLCC-GETUG-12/0203, EU-20238, NCT00055731
|
|
5.
|
Phase: Phase III Type: Treatment Status: Completed Age: Under 80 Sponsor: NCI, Other Protocol IDs: PR3, CAN-NCIC-PR3, ECOG-JPR03, MRC-PR07, SWOG-JPR3, EU-99013, NCI-T94-0110O, ISRCTN24991896, CDR0000064065, CALGB-9593, T94-0110, NCT00002633
|
|
6.
|
Phase: Phase III Type: Treatment Status: Closed Age: 16 and over Sponsor: NCI, Other Protocol IDs: PR7, CAN-NCIC-PR7, SWOG-JPR7, ICR-CTSU-JPR7, CDR0000066745, JPR7, NCT00003653
|
|
7.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-00-C-0137, MB-NAVY-99-04, NCI-T99-0097, T99-0097, NCT00020254
|
|
8.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: MDA-DM-99224
|
|
9.
|
Phase: Phase II Type: Treatment Status: Closed Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000069132, SWOG-S0032, S0032, NCT00028769
|